Income statement - Novozymes A/S


Audited by PwC
2010 2009
Note     DKK million  DKK million  
1 Revenue 6,557  4,682 
2 Cost of goods sold   2,936  2,565   
  Gross profit 3,621  2,117 
   
2 Sales and distribution costs 765  620 
2 Research and development costs 983  926 
2, 3 Administrative costs 466  441 
Other operating income, net 1,225  906   
Operating profit / EBIT 2,632  1,036 
7 Income before tax on investments in subsidiaries (546) 661 
4 Financial income 110  171 
4 Financial costs   107  302   
Profit before tax 2,089  1,566 
Corporation tax   501  413   
Net profit 1,588  1,153 
Proposed appropriation of net profit
Dividend to shareholders 504  358 
Revaluation reserve according to the equity method (408) (200)
Retained earnings   1,492  995   
1,588  1,153 
Proposed dividend per share DKK 8.00 DKK 5.75
My Report

0 pages added